FOCUS ON ALZHEIMER'S DISEASE
 LECTURES
             http://www.medafile.com/

HOME

J. Wesson Ashford, M.D.,Ph.D

A-Screen (Alzheimer Screening)

Alzheimer Evaluation Forms

Alzheimer Prevention

Alzheimer Hypotheses

Dr. Ashford Lectures

Alzheimer Links

AAGP03 JWA Slides

This page is an index of presentations, PowerPoint slides by Dr. Ashford

The Neuroplasticity Hypothesis of Alzheimer's Disease:
A Bio-Psycho-Social Systems Theory and
Neural-Network Perspective for Integrating the Alzheimer Field and
Providing an Approach to Treatment and Prevention
Buck Institute for Research on Aging
July 27, 2012
PowerPoint (2.5 meg)
Adobe PDF (750 k)

HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND
DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE?
NUCLEAR MEDICINE GRAND ROUNDS,
Stanford University, January 5, 2010
Part A – AD definition, neuropathology (4.5 MB)
Part B – AD and brain systems (1.4 MB)
Part C – AD brain scans - anatomical (4.5 MB)
Part D1 – AD brain scans - perfusion -SPECT (5.6 MB)
Part D2 – AD brain scans – metabolism - PET (.5 MB)
Part E – AD and amyloid PET ligands (1.5 MB)
Part F – AD and biomarkers for the future (1.5 MB)

TESTING A LEPTIN PRODUCT AS A NOVEL THERAPY FOR ALZHEIMER’S DISEASE (3.9 MB)
2nd conference of Clinical Trials on Alzheimer’s Disease (CTAD)
Las Vegas, October 30, 2009

A Computerized/Web-Based Test to Assess the Continuum of
Normal Memory/Cognition to Dementia (4 MB)
American Association of Geriatric Psychiatry
Honolulu, Hawaii, March 6, 2009

Alzheimer’s Disease and Research Directions for Prevention
Redwood City Public Library, sponsord by Stanford Health Library
Redwood City, California, May 30, 2007

Statistical Issues for Developing Alzheimer Screening Tests.
Alzheimer's Association Prevention Conference,
Washington, D.C. 6/19/05

Screening Elderly Clinic Patients for Early Dementia: Psychological Tests, Brain Scans, Genetic Tests, and CSF Biomarkers. 7th Annual Updates on Dementia, Stanford University Medical Center, 5/16/05

Stanford / VA Alzheimer Center talk on:
Mild Cognitive Impairment, Differential Diagnosis - 5/14/2004
Alzheimer Screening, Cost-Benefit Analysis - 10/8/2004

San Francisco, CA - Recent Advances in Alzheimer's disease - 10/5/2004
--- ---Handout----- Calabasas, CA - 10/14/2004

Geriatric Psychiatry: Review and Update:
Medical and Neurologic Aspects

    American Association of Geriatric Psychiatry, 2/24/02


Recent Advances in Alzheimer's Disease
     Kentucky Psychiatric Association - Keynote Address, 9/24/2002 (.1meg)

Delirium, Dementia, and Amnestic and other Cognitive Disorders
    Second Year Medical School, University of Kentucky, 2/12/2003

Neuropsychiatry in the Nursing Home
    Family Medicine Review Course, University of Kentucky, 2001-2002

Alzheimer Pathology and Neuroplasticity

Neurosci Society 11/2002: Clinical AD Onset AD Earlier with APOE4
- replaced with presentation to New York Academy of Sciences, 5/29/2003 - APOE Effects of Clinical Onset of AD, Epidemiology, and Gompertzian Aging Functions

- see draft of paper and Cincinnati debate paper

TOP 10 TREATMENTS  for preventing Alzheimer's disease (under development)

ALZHEIMER  HYPOTHESIS   (Ashford's Neuroplasticity Hypothesis)

Site constructed and maintained by:  J. Wesson Ashford, M.D., Ph.D.
    Electronic mail address:   washford@medafile.com

Forms and papers provided on this site may be copyrighted by their authors or the publishers.
HTML code copyright by J. Wesson Ashford, M.D., Ph.D., to retain rights for use.
Last update:  07/30/2012